Barriers to insulin injection therapy: Patient and health care provider perspectives

Diabetes Educator

Volumn 35, Issue 6, 2009, Pages 1014-1022

  Rubin, Richard R ^a   Peyrot, Mark ^b   Kruger, Davida F ^c   Travis, Luther B ^d  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c HENRY FORD HEALTH SYSTEM   (United States)

^d University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; INSULIN;

ADULT; ARTICLE; ATTITUDE; EDUCATIONAL STATUS; ENDOCRINOLOGY; ETHNIC GROUP; FEMALE; HEALTH EDUCATOR; HEALTH SURVEY; HUMAN; INCOME; INTERNET; MALE; MIDDLE AGED; PERCEPTION; PHYSICIAN; PSYCHOLOGICAL ASPECT; SUBCUTANEOUS DRUG ADMINISTRATION; UNITED STATES;

ADULT; ATTITUDE; EDUCATIONAL STATUS; ENDOCRINOLOGY; ETHNIC GROUPS; FEMALE; HEALTH EDUCATORS; HEALTH SURVEYS; HUMANS; HYPOGLYCEMIC AGENTS; INCOME; INJECTIONS, SUBCUTANEOUS; INSULIN; INTERNET; MALE; MIDDLE AGED; PERCEPTION; PHYSICIANS; UNITED STATES;

EID: 70749086591     PISSN: 01457217     EISSN: 15546063     Source Type: Journal    
DOI: 10.1177/0145721709345773     Document Type: Article

References (12)

1. Nathan DM, Buse JB, Davidson MB,et al.Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2009;32: 193-203.
2. Cramer JA, Pugh MJ The influence of insulin use on glycemic control: how well do adults follow prescriptions for insulin? Diabetes Care. 2005;28:78-83.
3. Snoek FJ, Mollema ED, Heine RJ, Bouter LM, van der Ploeg HM Development and validation of the Diabetes Fear of Injecting and Self-testing Questionnaire (D-FISQ): first findings. Diabet Med. 1997;14:871-876.
4. Mollema ED, Snoek FJ, Ader HJ, Heine RJ, van der Ploeg HM Insulin-treated diabetes patients with fear of self-injecting or fear of self-testing: psychological comorbidity and general well-being. J Psychosom Res. 2001;51:665-672.
5. Nakar S., Yitzhaki G., Rosenberg R., Vinker S. Transition to insulin in type 2 diabetes: family physicians' misconception of patients' fears contributes to existing barriers. J Diabetes Complicat. 2007;21:220-226.
6. Simmons JH, McFann KK, Brown AC,et al.Reliability of the Diabetes Fear of Injecting and Self-testing Questionnaire in pediatric patients with type 1 diabetes. Diabetes Care. 2007;30:987-988.
7. Peyrot M., Rubin RR Validity and reliability of an instrument for assessing health-related quality of life and treatment preferences: the Insulin Delivery System Rating Questionnaire. Diabetes Care. 2005;28:53-58.
8. Rubin RR, Peyrot M. Quality of life, treatment satisfaction, and treatment preference associated with use of a pen device delivering a premixed 70/30 insulin aspart suspension (aspart protamine suspension/soluble aspart) versus alternative treatment strategies. Diabetes Care. 2004;27:2495-2497.
9. Blevins T., Schwartz SL, Bode B.,et al.A study assessing an injection port for the administration of insulin. Diabetes Spectrum. 2008;1:197-202.
10. Peyrot M., Rubin RR, Lauritzen T., Snoek FJ, Matthews DR, Skovlund SE; the International DAWN Advisory Panel. Psychosocial problems and barriers to improved diabetes management: results of the cross-national Diabetes Attitudes, Wishes and Needs (DAWN) study. Diabet Med. 2005;22:1379-1385.
11. Polonsky WH, Fisher L., Guzman S., Villa-Caballero L., Edelman SV Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem. Diabetes Care. 2005;28: 2543-2545.
12. Rubin RR, Peyrot M. Factors affecting use of insulin pens by patients with type 2 diabetes. Diabetes Care. 2008;31:430-432.